Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 414
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT06902311 | Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous Integrated Boost for Early-Stage Breast Cancer (H-ASSIST) | ||
| NCT02281955 | De-intensification of Radiation and Chemotherapy for Low-Risk HPV-related Oropharyngeal SCC: Follow-up Study | ||
| NCT06348147 | Dara-RVd Induction for Newly Diagnosed Multiple Myeloma With Autologous Stem Cell Transplantation | ||
| NCT05722847 | Risk Stratification for Patients With Hospital-diagnosed Advanced Lung Cancer | ||
| NCT01137643 | Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer | ||
| NCT01726738 | LCCC 1128: Open Label Phase II Trial of the BRAF Inhibitor (Dabrafenib) and the MEK Inhibitor (Trametinib) in Unresectable Stage III and Stage IV BRAF Mutant Melanoma; Correlation of Resistance With the Kinome and Functional Mutations | ||
| NCT05311670 | Pre-Implementation Study of Improving Thoracic Surgical Care Using Electronic Patient-Reported Outcomes (ePROS) | ||
| NCT02651883 | Effect of Human Papillomavirus Self-Collection on Cervical Cancer Screening in High Risk Women: My Body, My Test 3 | ||
| NCT04271254 | PET/MR Characterization of Renal Cell Carcinomas | ||
| NCT02609503 | Pembrolizumab + Radiation for Locally Adv SCC of the Head and Neck (SCCHN) Not Eligible Cisplatin | ||
| NCT06413797 | Little Cigar and Cigarillo Warnings for Youth | ||
| NCT01789983 | Feasibility of an Evidence-based Walking Program in Cancer Pts 60+ During Chemotherapy | ||
| NCT01845519 | Step by Step: A Tailored Walking Intervention for Breast Cancer Survivors | ||
| NCT03196037 | Feasibility of an 8-week Tai Chi Chuan Intervention for Breast Cancer Survivors | ||
| NCT06158139 | Autologous CAR-T Cells Targeting B7-H3 in PDAC | ||
| NCT03761706 | Impact of Home-based Aerobic and Strength Exercises During Chemotherapy for Early Breast Cancer on Biomarkers of Aging | ||
| NCT05823740 | Measuring Changes in Body Composition and Physical Function in Patients With Childhood Cancers | ||
| NCT05630131 | ctDNA in Subjects With Muscle-invasive Bladder Cancer Treated With Trimodality Therapy | ||
| NCT00003392 | High-Dose Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Metastatic Breast Cancer | ||
| NCT04176497 | PSMA-PET/MRI Unfavorable-Risk Target Volume Pilot Study | ||
| NCT00307255 | Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Gemcitabine in Treating Patients With Advanced Metastatic Solid Tumors | ||
| NCT02835911 | Clinical Cohort of Lymphoma Patients in Malawi | ||
| NCT06965192 | Designing Visual Tools to Enhance Cancer Surgeon Decision-making | ||
| NCT03077243 | P53 Mutational Status and cf HPV DNA for the Management of HPV-associated OPSCC | ||
| NCT01688336 | FOLFIRINOX for Unresectable Locally Advanced and Borderline Resectable Pancreatic Cancer | ||
| NCT03721068 | Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma | ||
| NCT07069595 | PREDICT-RD: ctDNA Surveillance in TNBC With Residual Disease | ||
| NCT03672396 | Home-based Exercise Intervention for Patients With Metastatic Prostate Cancer | ||
| NCT05742386 | Impact of Standing Orders Optimization | ||
| NCT00227032 | Erlotinib in Treating Patients With Progressive Glioblastoma Multiforme | ||
| NCT05366179 | Autologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3Tc | ||
| NCT02043470 | Retinal Oxygen Function After Radiation Therapy | ||
| NCT03620019 | Denosumab + PD-1 in Subjects With Stage III/ IV Melanoma | ||
| NCT03717844 | Registry for Adults With Plasma Cell Disorders (PCD's) | ||
| NCT01578967 | Induction Chemo w/ABVD Followed by Brentuximab Vedotin Consolidation in Newly Diagnosed, Non-Bulky Stage I/II Hodgkin Lymphoma | ||
| NCT04974489 | Correcting Public Misperceptions About Very Low Nicotine Content Cigarettes | ||
| NCT00280735 | Ph II Adjuvant Carboplatin/Docetaxel in Curatively Resected Stage I-IIIA NSCLC | ||
| NCT02798224 | A Patient Portal Tool, E-assist, for Supporting CRC Screening | ||
| NCT01262820 | Pazopanib In Stage IIIB/IV NSCLC Lung Cancer After Progression on First Line Therapy Containing Bevacizumab | ||
| NCT00573690 | Sorafenib Combined With Cisplatin and Etoposide or Carboplatin and Pemetrexed in Treating Patients With Metastatic Solid Tumors | ||
| NCT04418895 | Neoadjuvant Therapy for Localized Rectal Adenocarcinoma | ||
| NCT06361056 | Mobile Health App to Promote Participation of Black Women in Breast Cancer Clinical Trials | ||
| NCT00998101 | Carboplatin, Ixabepilone, and Cetuximab in Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Untreated With Chemotherapy | ||
| NCT03885830 | Precision Dosing of Tyrosine Kinase Inhibitors in CML Patients | ||
| NCT06075316 | Improving Thoracic Surgical Care Using Electronic Patient-Reported Outcomes (ePROS) | ||
| NCT05362955 | 5-fluorouracil Following Cervical Intraepithelial Neoplasia Treatment Among HIV-positive Women in East Africa | ||
| NCT07068477 | Adaptation of a Values Assessment Tool | ||
| NCT06902376 | XL092 and Cemiplimab in BRAF WT Thyroid Cancer | ||
| NCT03951090 | Geriatric Assessment Reporting in Real Time (GARRT) in Non-electively Hospitalized Older Cancer Patients | ||
| NCT06848491 | Using Tailored mHealth Strategies to Promote Weight Management Among Adolescent and Young Adult Cancer Survivors |
